low-pass whole genome sequencing: a new standard for genome wide association studies at the cost of genotyping
dr. linda wang
global product manager and dr. joseph pickrell, the co-founder and ceo of gencove

low-pass whole genome sequencing (lp-wgs) allows a wide variety of research applications including highly accurate risk score calculations, ancestry analysis, cnv calling, trait mapping, polygenic risk scoring and high-powered genome-wide association studies. in this webinar, we explore how the combination of bgi’s ultra-efficient lp-wgs service and gencove’s imputation and analysis platform is enabling access to human whole genome information at the cost of genotyping arrays.



what will you learn in this webinar?
– an overview of low pass whole genome sequencing and recommended coverage levels for different applications
– considerations and common challenges in lp-wgs research studies
– a case study comparing the relative accuracy for polygenic risk prediction between lp-wgs and array genotyping on 120 dna samples derived from african and european-ancestry individuals that are part of the 1000 genomes project

the presentation will take around 30 minutes. register now, it’s free, quick and easy.

once you have registered for the webinar, you will be able to view it on-demand. don’t have time to watch the webinar but want to learn more about our low-pass whole genome sequencing? email us: 

register here
to submit your enquiry, you must check the “i agree …“ box for the privacy policy.